Bradley L. Pyburn
Known title: DirectorCIK: 0002047652
Associated companies
Transaction History
| BLKB | ▲ Buy | Grant | 7,834 | $0 | 8/3/2026 | View on chart |
| BLKB | ▲ Buy | Grant | 3,670 | $0 | 8/1/2025 | View on chart |
| BLKB | ▲ Buy | Grant | 1,599 | $0 | 12/4/2024 | View on chart |
| BLKB | ▲ Buy | Grant | 7,834 | $0 | 8/3/2026 | View on chart |
| BLKB | ▲ Buy | Grant | 3,670 | $0 | 8/1/2025 | View on chart |
| BLKB | ▲ Buy | Grant | 1,599 | $0 | 12/4/2024 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Blackbaud Sets Date for Q3 2026 Earnings Release
Blackbaud announced the specific date for its upcoming third-quarter 2026 financial results. This standard corporate disclosure provides a timeline for investors to monitor future performance updates. The company currently trades with a trailing P/E of 14.3, while the average analyst target sits at $51.50.
Blackbaud Sets Date for Q3 2026 Earnings Release. Blackbaud announced the specific date for its upcoming third-quarter 2026 financial results. This standard corporate disclosure provides a timeline for investors to monitor future performance updates. The company currently trades with a trailing P/E of 14.3, while the average analyst target sits at $51.50.